New diabetes clinical trial: Efficacy of FDC Regimen of Dapagliflozin/Metformin Compared to Co-administered Dual Therapy on Glycemic Control, Satisfaction and Adherence in Chinese Patients With T2DM

Published on: March 24, 2024 at 11:00PM
Conditions: Type 2 Diabetes Mellitus (T2DM)
Interventions: Drug: Xigduo (Dapagliflozin and Metformin hydrochloride extended-release) tablets; Drug: Dapagliflozin tablets and Metformin HCl extended-release tablets
Sponsors: AstraZeneca
Not yet recruiting
https://ift.tt/an6wodb